✦ LIBER ✦

Serum from patients with non-hodgkin's lymphoma(nhl) inhibits T-cell colony formation

✍ Scribed by Robert E. Hutchison; Diane G. Tice; Frederick R. Davey

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 726 KB
Volume: 25
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830250204

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Soluble fas in the serum of patients wit

Soluble fas in the serum of patients with non-Hodgkin's lymphoma: Higher concentrations in angioimmunoblastic T-cell lymphoma

✍ Yufu, Yuji; Choi, Ilseung; Hirase, Nobuhisa; Tokoro, Akihiro; Noguchi, Yumi; Got 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 3 views

The soluble form of Fas (sFas) can block apoptosis induced by the Fas ligand in vitro. A recent report demonstrated that mice injected with sFas displayed autoimmune features. Therefore, an elevated serum concentration of sFas may be associated with lymphoproliferation and autoimmune diseases. We me

Inhibition of human lymphoma cell-line c

Inhibition of human lymphoma cell-line colony formation by lymphocytes from patients with lymphoma and cancer hospital employees

✍ B. Drewinko; G. M. Mavligit; U. Ambus; E. M. Hersh 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

Inducible lymphokine-activated killer (L

Inducible lymphokine-activated killer (LAK) cell activity in the peripheral blood of patients with relapsed/refractory non-Hodgkin's lymphoma (NHL)

✍ Kenneth W. Zamkoff; Nora P. Watman; David B. Duggan; Bernard J. Poiesz; Arlan J. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB

Therapy with recombinant interleukin-2 (rIL-2) induces clinical response in a significant number of patients with refractory malignant disease. Very few patients with non-Hodgkin's lymphoma (NHL) have been treated with rIL-2. The present study sought to determine if peripheral blood mononuclear cell

Functional aspects of T-cells from patie

Functional aspects of T-cells from patients with non-Hodgkin's lymphoma. Responses to self, TNP-modified self, and alloantigens

✍ J. Bruce Smith; Regina P. Knowlton; David T. Harris 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 2 views

Competitive polymerase chain reaction to

Competitive polymerase chain reaction to quantify tumor cells in peripheral blood of patients with T(14;18)-bearing follicular non-Hodgkin's lymphoma: An exploratory study in 8 patients

✍ Marc Debled; Isabelle Hostein; Thérèse Astier-Gin; Houchingue Eghbali; Françoise 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 115 KB 👁 3 views

Detection of residual disease in follicular lymphoma is hampered by the observation of t(14;18)-bearing cells in the blood of healthy adult humans. To overcome this problem, we decided to validate a quantification method of t(14;18)bearing cells and test it in t(14;18)-bearing follicular lymphomas (

Feasibility and toxicity of high-dose th

Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: Survey from a single institution

✍ Massimo Magagnoli; Luca Castagna; Monica Balzarotti; Barbara Sarina; Inna Timofe 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views